Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

BioCorRx (BICX) Operating Leases (2019 - 2025)

Historic Operating Leases for BioCorRx (BICX) over the last 7 years, with Q3 2025 value amounting to $169443.0.

  • BioCorRx's Operating Leases fell 1881.38% to $169443.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $169443.0, marking a year-over-year decrease of 1881.38%. This contributed to the annual value of $159127.0 for FY2024, which is 135387.85% up from last year.
  • BioCorRx's Operating Leases amounted to $169443.0 in Q3 2025, which was down 1881.38% from $179555.0 recorded in Q2 2025.
  • In the past 5 years, BioCorRx's Operating Leases ranged from a high of $516132.0 in Q1 2021 and a low of $10945.0 during Q4 2023
  • In the last 5 years, BioCorRx's Operating Leases had a median value of $216537.0 in 2023 and averaged $265705.2.
  • Per our database at Business Quant, BioCorRx's Operating Leases crashed by 9396.4% in 2023 and then soared by 135387.85% in 2024.
  • BioCorRx's Operating Leases (Quarter) stood at $315672.0 in 2021, then tumbled by 42.56% to $181328.0 in 2022, then tumbled by 93.96% to $10945.0 in 2023, then skyrocketed by 1353.88% to $159127.0 in 2024, then grew by 6.48% to $169443.0 in 2025.
  • Its last three reported values are $169443.0 in Q3 2025, $179555.0 for Q2 2025, and $189468.0 during Q1 2025.